|
|
|
Pmv Pharmaceuticals Inc (PMVP) |
|
Pmv Pharmaceuticals Inc
PMVP's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Pmv Pharmaceuticals Inc 's sales fell
in III. Quarter 2023 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.75 %
Pmv Pharmaceuticals Inc net loss decreased from $-18 millions, to $-17 millions in III. Quarter 2023,
• More on PMVP's Growth
|
|
Pmv Pharmaceuticals Inc
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.58 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.71.
• More on PMVP's Valuation
|
|
|
|
|
Pmv Pharmaceuticals Inc
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 4.58 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.71.
Pmv Pharmaceuticals Inc Price to Book Ratio is at 0.32 lower than Industry Avg. of 84.25. and higher than S&P 500 Avg. of 0
• More on PMVP's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
